Redeye returns with a more in-depth take on the Q4 results. We appreciate the company’s focus on establishing OPRA at key centres but assume a slower wide adoption of the technology for the coming years, mainly owing to bottlenecks in educational and training capacity. As such, we down our sales estimates and include a small equity raise during calendar year 2026 in our DCF model, somewhat lowering our fair value range.
LÄS MER
